Embody, Inc. Announces $10.4 Million Series C Funding Round

Funds to Support Commercial Expansion and Post-Market Clinical Studies of Tapestry® for tendon and ligament injuries.

Norfolk, VA, September 20, 2022 — Embody, Inc., a privately-held medical device company focused on soft tissue healing, announced today that it closed a $10.4 million Series C funding round led by Genesis Innovation Group’s cultivate(MD) Capital Funds LP. The financing will enable Embody to expand its world-class operations, post-market clinical studies of the recently launched Tapestry RC System for rotator cuff, and prepare for the commercial launch of ActivBraid™ high-strength collagen-based suture technology in 2023.

Read More